In line with this, we measured strong expression changes of FXR downstream targets in hepatic (bsep, cyp7a1, shp) and ileal (shp, fgf15) tissue of NASH rats treated with cilofexor (Supplementary Figure S2). The gene discussed is CYP7A1; the disease is metabolic dysfunction-associated steatohepatitis.